Angiogenic systemic response to the hypoxic microenvironment in prostate tumorigenesis: A pilot study

Area of Science:

• Urology
• Oncology
• Molecular Biology

Background:

• Hypoxia significantly impacts tumor microenvironments.
• Angiogenesis plays a critical role in prostate tumor progression.
• Understanding molecular changes is vital for prostate pathology.

Purpose of the Study:

• Investigate altered angiogenesis in hypoxic prostate tumors.
• Correlate angiogenic factors with clinicopathological variables.
• Identify potential biomarkers for early prostate cancer diagnosis.

Main Methods:

• Case-control study with 87 prostate tumor patients and 40 controls.
• Serum analysis of Hypoxia-inducible factor (HIF)-1α, FGF-2, VEGF, MMP-2, MMP-9, TSP-1, and soluble VEGF receptor.
• Comparison of angiogenic profiles between benign prostatic hyperplasia (BPH), prostate cancer (PCa), and healthy subjects.

Main Results:

• Elevated inflammation (IL-6) in PCa and BPH patients compared to controls.
• Significantly higher HIF-1α levels in PCa patients versus BPH and controls.
• PCa showed angiogenesis abnormalities: upregulated FGF-2, VEGF, MMP-2, MMP-9; suppressed TSP-1 and soluble VEGF receptor. BPH showed upregulated FGF-2 and VEGF.

Conclusions:

• Altered angiogenesis and inflammation are evident in hypoxic prostate tumors.
• Specific angiogenic factors (HIF-1α, VEGF, MMPs) are dysregulated in PCa and BPH.
• These findings support the clinical utility of angiogenic markers for early diagnosis and personalized treatment of prostate diseases.